By: Michael Mezher
Welcome to another installment of This Week at FDA, your weekly source for updates @ big and small @ on FDA, drug and medical device regulation, and what we@re reading from around the web. This week, FDA@s top medical device regulator issued a joint statement with his counterpart at the Centers for Medicare and Medicaid Services (CMS), stressing the need for FDA to extend its oversight of laboratory developed tests (LDTs).